The European Medicines Agency has been notified by Merck Sharp & Dohme Ltd of its decision to withdraw its application for a centralised marketing authorisation for the medicine Vorinostat MSD (Vorinostat), 100 mg hard capsules.
The details can be read here.
No comments:
Post a Comment